» Articles » PMID: 3024558

Transfection of Human Skeletal Muscle Cells with SV40 Large T Antigen Gene Coupled to a Metallothionein Promoter

Overview
Journal Ann Neurol
Specialty Neurology
Date 1986 Nov 1
PMID 3024558
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

We have undertaken to increase the proliferative capacity of cultured human skeletal myocytes by transfection with a plasmid construct that contains the immortalizing and transforming large T antigen gene of simian virus 40 (SV40) under the control of a zinc-sensitive metallothionein promoter. This construct was chosen to permit rapid growth of transformants in zinc-containing medium, which induces high levels of T antigen expression, and muscle-specific differentiation after withdrawal of exogenous zinc, which reduces levels of T antigen. When grown in 100 microM Zn2+, transformed myocytes expressed the large T antigen, divided rapidly, and acquired an apparently unlimited proliferative capacity. Transfer of these cells to a zinc-poor medium resulted in decreased T antigen immunofluorescence, growth rate, and saturation density as well as a return to a physiological spindle morphology. Despite transformation, these cells expressed differentiation markers characteristic of myoblasts: the B isoform of creatine kinase, and surface antigens 5.1H11, D5, and Thy 1 in the presence or absence of Zn2+. When grown to high density in a serum-poor medium, these cells differentiated further into typical multinucleated myotubes that expressed the M isoform of creatine kinase and increased levels of surface antigen 5.1H11, creatine kinase, and nicotinic acetylcholine receptors, but no detectable Thy 1 antigen. The specific activity of these differentiation markers was higher when the cells were grown in the absence of added zinc. These results indicate that transformation of human skeletal myocytes with a regulatable SV40 large T antigen gene allows an increase of the proliferative capacity of these cells with preservation of their capacity to differentiate in a physiological manner.

Citing Articles

Characterization of human vascular smooth muscle cells transformed by the early genetic region of SV40 virus.

Legrand A, Greenspan P, Nagpal M, Nachtigal S, Nachtigal M Am J Pathol. 1991; 139(3):629-40.

PMID: 1653520 PMC: 1886216.


MELAS mutation in mtDNA binding site for transcription termination factor causes defects in protein synthesis and in respiration but no change in levels of upstream and downstream mature transcripts.

Chomyn A, Martinuzzi A, Yoneda M, Daga A, Hurko O, Johns D Proc Natl Acad Sci U S A. 1992; 89(10):4221-5.

PMID: 1584755 PMC: 49053. DOI: 10.1073/pnas.89.10.4221.


Marked replicative advantage of human mtDNA carrying a point mutation that causes the MELAS encephalomyopathy.

Yoneda M, Chomyn A, Martinuzzi A, Hurko O, Attardi G Proc Natl Acad Sci U S A. 1992; 89(23):11164-8.

PMID: 1454794 PMC: 50510. DOI: 10.1073/pnas.89.23.11164.


Cell culture systems and in vitro toxicity testing. Technical report no. 4 of the Johns Hopkins Center for Alternatives to Animal Testing (CAAT): technical workshop of June 13-15, 1990.

Cytotechnology. 1992; 8(2):129-76.

PMID: 1368813